Sheyhidin I, Nabi G, Hasim A, Zhang RP, Ainiwaer J, Ma H, Wang H. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17(32): 3745-3751 [PMID: 21990957 DOI: 10.3748/wjg.v17.i32.3745]
Corresponding Author of This Article
Ayshamgul Hasim, PhD, Department of Pathology, College of Basic Medicine, Medical University of Xinjiang, Xinyi Road 393, 830011 Urumqi, Xinjiang, China. ayshamgul75@sina.com
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Aug 28, 2011; 17(32): 3745-3751 Published online Aug 28, 2011. doi: 10.3748/wjg.v17.i32.3745
Table 1 Polymerase chain reaction primers used for the detection of Toll-like receptors
TLR
Forward
Reverse
TLR3
AGTGCCGTCTATTTGCCACACA
AACAGTGCACTTGGTGGTGGAG
TLR4
TCTTCAACCAGACCTCTACATTCCA
GGAACATCCAGAGTGACATCACAG
TLR7
CCGTGACAATTACCTGGCCTTC
CAGGGCCTTCAGCTGGTTTC
TLR9
AGGATGATGCCAGGATGATGTC
TCAGGTCCAGGTTCTTGGTTGAG
β-actin
GGCACCCAGCACAATGAAG
CCGATCCACACGGAGTACTTG
Table 2 Statistical analysis of Toll-like receptor expression and clinicopathologic factors in esophageal carcinoma
Characteristics
TLR3
P
TLR4
P
TLR7
P
TLR9
P
Positive (%)
Positive (%)
Positive (%)
Positive (%)
Normal control (n = 87)
7 (8)
5 (5.7)
8 (9.2)
4 (4.6)
Tumor differentiation
61 (70.1)
63 (72.4)
58 (66.7)
68 (78.2)
W (n = 30)
22 (75.3)
0.889
22 (75.3)
0.539
14 (46.7)
0.003
18 (60.0)
0.004
M (n = 29)
20 (69.1)
19 (65.6)
19 (65.6)
23 (79.3)
P (n = 28)
19 (67.9)
22 (78.6)
25 (89.3)
27 (96.4)
Depth of invasion
≤ muscularis (n = 37)
18 (48.6)
< 0.001
27 (73.1)
0.92
23 (62.2)
0.002
27 (73.1)
0.314
≥ adventitia (n = 50)
43 (86.0)
36 (72.0)
35 (66.0)
41 (82.0)
LN metastasis
Negative (n = 34)
18 (52.9)
0.005
20 (58.8)
0.023
26 (76.5)
0.12
29 (85.3)
0.197
Positive (n = 53)
43 (81.1)
43 (81.1)
32 (60.3)
39 (73.6)
Ethnic groups
Han (n = 30)
23 (76.7)
> 0.05
22 (73.3)
> 0.05
17 (56.7)
> 0.05
23 (76.7)
> 0.05
Uyghur (n = 25)
18 (72.0)
20 (80.0)
16 (64.0)
20 (80.0)
Kazak (n = 32)
20 (62.5)
21 (65.6)
25 (78.1)
25 (78.1)
Table 3 The percentage expression of Toll-like receptors in each cellular type within esophageal squamous cell carcinoma tissues
Tumor cells
Fibroblast
MICs
Factors
Positive cases (%)
Positive cases (%)
Positive cases (%)
TLR3
61 (70.1)
3 (3.4)
4 (4.6)
TLR4
63 (72.4)
8 (9.2)
47 (48.3)
TLR7
58 (66.7)
5 (5.7)
2 (2.3)
TLR9
68 (78.2)
53 (60.9)
12 (13.8)
Table 4 Analysis of the relationship between the expression of Toll-like receptors in each cellular type with the clinicopathologic characteristics of esophageal squamous cell carcinoma n (%)
Factors
Tumor Grade
Depth of invasion
LN metastasis
W
M
P
≤muscularis
≥adventitia
Negative
Positive
Number of cases
30
29
28
37
50
34
53
TLR4 MICs (+)
19 (63.3)
16 (55.2)
12(42.9)
12(32.4)
35(70)
14(41.2)
33(62.3)
P
0.245
0.001
0.018
TLR9 fibroblast (+)
20 (66.7)
18 (62.1)
17(60.7)
30(81.1)
23(43.4)
29(85.3)
24(45.3)
P
0.885
0.001
0.006
Citation: Sheyhidin I, Nabi G, Hasim A, Zhang RP, Ainiwaer J, Ma H, Wang H. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17(32): 3745-3751